L Yip1, R C Dart, K M Hurlbut. 1. Rocky Mountain Poison and Drug Center and Denver Health Medical Center, Department of Surgery, University of Colorado Health Science Center 80220, USA.
Abstract
OBJECTIVE: To report the indications and adverse events associated with administration of the oral N-acetylcysteine preparation by the intravenous route. DESIGN: Retrospective consecutive case series analysis of 226,720 Toxic Exposure Surveillance System data sheets from a certified regional poison center during the period January 1, 1992 through December 31, 1993. SETTING: A regional poison center certified by the American Association of Poison Control Centers. PATIENTS: Seventy-six patients treated with the oral N-acetylcysteine solution by the intravenous route. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We report the indications and adverse events associated with the intravenous administration of the oral N-acetylcysteine preparation. Four (4/76, 5.3%) patients developed adverse events attributable to N-acetylcysteine. None of these events involved hemodynamic, cardiovascular, or pulmonary effects. All reactions occurred during infusion of the initial N-acetylcysteine dose. There were three (3/76, 3.9%) deaths overall; however, they were not attributable to the intravenous administration of the oral N-acetylcysteine preparation. CONCLUSIONS: Intravenous administration of the oral N-acetylcysteine preparation appears to have limited adverse effects and offers another mechanism of delivery of the potentially lifesaving N-acetylcysteine when oral administration is not possible.
OBJECTIVE: To report the indications and adverse events associated with administration of the oral N-acetylcysteine preparation by the intravenous route. DESIGN: Retrospective consecutive case series analysis of 226,720 Toxic Exposure Surveillance System data sheets from a certified regional poison center during the period January 1, 1992 through December 31, 1993. SETTING: A regional poison center certified by the American Association of Poison Control Centers. PATIENTS: Seventy-six patients treated with the oral N-acetylcysteine solution by the intravenous route. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We report the indications and adverse events associated with the intravenous administration of the oral N-acetylcysteine preparation. Four (4/76, 5.3%) patients developed adverse events attributable to N-acetylcysteine. None of these events involved hemodynamic, cardiovascular, or pulmonary effects. All reactions occurred during infusion of the initial N-acetylcysteine dose. There were three (3/76, 3.9%) deaths overall; however, they were not attributable to the intravenous administration of the oral N-acetylcysteine preparation. CONCLUSIONS: Intravenous administration of the oral N-acetylcysteine preparation appears to have limited adverse effects and offers another mechanism of delivery of the potentially lifesaving N-acetylcysteine when oral administration is not possible.
Authors: Vikhyat S Bebarta; Louise Kao; Blake Froberg; Richard F Clark; Eric Lavonas; Ming Qi; Joao Delgado; John McDonagh; Tom Arnold; Oladapo Odujebe; Gerry O'Malley; Claudia Lares; Elizabeth Aguilera; Richard Dart; Kennon Heard; Chriss Stanford; Jamie Kokko; Greg Bogdan; Carrie Mendoza; Sara Mlynarchek; Sean Rhyee; Jason Hoppe; William Haur; Hock Heng Tan; Nguyen Nguyen Tran; Shawn Varney; Amy Zosel; Jennifer Buchanan; Mohammed Al-Helial Journal: Clin Toxicol (Phila) Date: 2010-06 Impact factor: 4.467
Authors: Sombat Treeprasertsuk; Srivicha Krudsood; Thanawat Tosukhowong; Wirach Maek-A-Nantawat; Suparp Vannaphan; Tosaporn Saengnetswang; Sornchai Looareesuwan; Walter F Kuhn; Gary Brittenham; James Carroll Journal: Southeast Asian J Trop Med Public Health Date: 2003-03 Impact factor: 0.267